Use of SSRI, but not SNRI, increased upper and lower gastrointestinal bleeding a nationwide population-based cohort study in Taiwan

Medicine (United States)

Volumn 94, Issue 46, 2015, Pages e2022-

  Cheng, Yuan Lung ^a,c   Hu, Hsiao Yun ^b,e   Lin, Xi Hsuan ^a,c   Luo, Jiing Chyuan ^a,c,f   Peng, Yen Ling ^a,c   Hou, Ming Chih ^a,c,d   Lin, Han Chieh ^a,c   Lee, Fa Yauh ^a,c  

^a Department of Medicine ^*  (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d Endoscopic Center for Diagnosis and Therapy   (Taiwan)

^e TAIPEI CITY HOSPITAL   (Taiwan)

^f TAIPEI MUNICIPAL GAN DAU HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CITALOPRAM; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MILNACIPRAN; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID; TICLOPIDINE; WARFARIN; ANTIDEPRESSANT AGENT;

ADULT; AGE; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERTENSION; INCIDENCE; LIVER CIRRHOSIS; LOWER GASTROINTESTINAL BLEEDING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; PEPTIC ULCER; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TAIWAN; UPPER GASTROINTESTINAL BLEEDING; AGED; CHEMICALLY INDUCED; FACTUAL DATABASE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS; SEROTONIN UPTAKE INHIBITORS; TAIWAN;

EID: 84948690210     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002022     Document Type: Article

References (36)

1. Schatzberg AF. New indications for antidepressants. J Clin Psychiatry. 2000;61(Suppl 11):9-17.
2. de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 1999;319: 1106-1109.
3. Andrade C, Sandarsh S, Chethan KB, et al. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry. 2010;71:1565-1575.
4. Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2008;27:31-40.
5. de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry. 2008;65:795-803.
6. Paton C, Ferrier IN. SSRIs and gastrointestinal bleeding. BMJ. 2005;331:529-530.
7. Dalton SO, Johansen C, Mellemkjaer L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003;163:59-64.
8. de Abajo FJ, Gil MJ, Bryant V, et al. Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested casecontrol study in a new general practice database. Eur J Clin Pharmacol. 2013;69:691-701.
9. Anglin R, Yuan Y, Moayyedi P, et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:811-819.
10. Dall M, Schaffalitzky de Muckadell OB, Lassen AT, et al. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2009;7:1314-1321.
11. Lin CC, Hu HY, Luo JC, et al. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study. Aliment Pharmacol Ther. 2013;38:1119-1128.
12. Blasco-Fontecilla H, de Leon J. Lower gastrointestinal bleeding and paroxetine use: two case reports. Psychosomatics. 2012;53:184-187.
13. Ahsberg K, Hoglund P, Kim WH, et al. Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of nonvariceal upper and lower gastrointestinal bleeding. Scand J Gastroenterol. 2010;45:1404-1415.
14. Wessinger S, Kaplan M, Choi L, et al. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther. 2006;23:937-944.
15. Luo JC, Leu HB, Huang KW, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ. 2011;183:E1345-1351.
16. Tseng CL, Chen YT, Huang CJ, et al. Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide populationbased case-crossover study. Aliment Pharmacol Ther. 2015;42: 599-606.
17. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med. 2006;119:719-727.
18. Abdel Salam OM. Fluoxetine and sertraline stimulate gastric acid secretion via a vagal pathway in anaesthetised rats. Pharmacol Res. 2004;50:309-316.
19. Coupland C, Dhiman P, Morriss R, et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551.
20. Opatrny L, Delaney JA, Suissa S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol. 2008;66:76-81.
21. Lewis JD, Strom BL, Localio AR, et al. Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidem Dr Saf. 2008;17:328-335.
22. Tatsumi M, Groshan K, Blakely RD, et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340:249-258.
23. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol. 1995;90:206-210.
24. Wu CY, Wu CH, Wu MS, et al. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H. pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol. 2009;7:427-431.
25. Collen MJ, Abdulian JD, Chen YK. Age does not affect basal gastric acid secretion in normal subjects or in patients with acid-peptic disease. Am J Gastroenterol. 1994;89:712-716.
26. Wang YP, Chen YT, Tsai CF, et al. Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am J Psychiatry. 2014;171:54-61.
27. Ehrenkranz JR. Effects of sex steroids on serotonin uptake in blood platelets. Acta Endocrinol (Copenh). 1976;83:420-428.
28. Akarasereenont P, Tripatara P, Chotewuttakorn S, et al. The effects of estrone, estradiol and estriol on platelet aggregation induced by adrenaline and adenosine diphosphate. Platelets. 2006;17:441-447.
29. Lee YC, Tseng PH, Liou JM, et al. Performance of a one-step fecal sample-based test for diagnosis of Helicobacter pylori infection in primary care and mass screening settings. J Formos Med Assoc. 2014;113:899-907.
30. Dall M, Schaffalitzky de Muckadell OB, Møller Hansen, et al. Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors. Scand J Gastroenterol. 2011;46:1039-1044.
31. Chang SS, Hu HY. Lower Helicobacter pylori infection rate in chronic kidney disease and end-stage renal disease patients with peptic ulcer disease. Chin Med Assoc. 2014;77:354-359.
32. Luo JC, Leu HB, Hou MC, et al. Nonpeptic ulcer, nonvariceal gastrointestinal bleeding in hemodialysis patients. Am J Med. 2013;126:e225-e232.
33. Kelly JP, Kaufman DW, Koff RS, et al. Alcohol consumption and the risk of major upper gastrointestinal bleeding. Am J Gastroenterol. 1995;90:1058-1064.
34. Kaufman DW, Kelly JP, Wiholm BE, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol. 1999;94:3189-3196.
35. Huang MC, Chen CC. Alcohol dependence in Taiwan: from epidemiology to biomedicine. J Exp Clin Med. 2012;4:108-112.
36. Tsai AC, Liou JC, Chang JMC, et al. Prevalence and determinants of dietary supplement and non-prescription medicine use by men and women over 53 years old in Taiwan. Results from a populationbased cross-sectional survey. Aust J Ageing. 2006;25:191-197.